No parkinsonism in SCA2 and SCA3 despite severe neurodegeneration of the dopaminergic substantia nigra.
Schöls L, Reimold M, Seidel K, Globas C, Brockmann K, Hauser TK, Auburger G, Bürk K, den Dunnen W, Reischl G, Korf HW, Brunt ER, Rüb U.
Schöls L, et al. Among authors: reischl g.
Brain. 2015 Nov;138(Pt 11):3316-26. doi: 10.1093/brain/awv255. Epub 2015 Sep 11.
Brain. 2015.
PMID: 26362908